RxAnte Secures Funding led by Aberdare Ventures

RxAnte, a healthcare improvement company has raised Series A financing led by Aberdare Ventures with additional backing from the West Health Investment Fund. The financing will be used to further develop RxAnte's proprietary technologies, commercialize its current offerings, and expand the company's impact on the quality of medication use.

North AmericaUSBriefs